COMPANY OVERVIEW

Sofregen Medical Inc. is a privately-held medical technology company focused on developing innovative silk-based solutions for soft tissue defects.

Founded in 2014 in Cambridge, Massachusetts to advance technology developed by scientists at Tufts University and the University of Pittsburgh, Sofregen is pioneering the use of silk to offer more medical and aesthetic options for surgeons and physicians to address soft tissue regeneration.  The cornerstone of Sofregen’s technology is silk, nature’s healing fiber which has been shown to exhibit favorable biocompatibility, absorbability and facilitate native tissue generation.

Sofregen has a number of silk-based innovations under development and plans to introduce a series of new products, including injectables and other advanced tools for soft tissue repair, providing surgeons and patients around the world with enhanced options and better solutions.

Sofregen is most recently the new team behind SERI® Surgical Scaffold, the only silk-based surgical mesh approved for soft tissue support and repair and the choice of hundreds of surgeons in the U.S.  Sofregen is committed to advancing the SERI® Surgical Scaffold product line, continually improving pliability, functionality and design.

Our seasoned leadership team, scientific advisors, and Board of Directors represent some of the country’s most prominent scientists, physicians, and business professionals in the field of medical technology development and biomedicine.

Our Management Team

Howard Weisman
Chairman

Howard Weisman

  Read more
Christopher White
President and Chief Operating Officer

Christopher White

  Read more
Anh Hoang, Ph.D.
Chief Science Officer

Anh Hoang, Ph.D.

  Read more
Milan Kofol
Chief Financial Officer

Milan Kofol

  Read more
David Iwanicki
National Sales Director

David Iwanicki

  Read more
Daniel Huff
Controller

Daniel Huff

  Read more

Board of Directors

Howard Weisman

Chairman

Amir Nashat

Managing Partner at Polaris

S. Douglas Sheldon

Executive Chairman, Indochina Healthcare Ltd.

Scientific Advisory Board

Peter Rubin

Chair of the Department of Plastic Surgery at the University of Pittsburgh

R. Rox Anderson

Professor at Harvard Medical School

Kacey Marra

Associate Professor in the Department of Plastic Surgery at the University of Pittsburgh

David Kaplan

Professor of Engineering at Tufts University

Fio Omenetto

Associate Dean for Research School of Engineering

Investors

Polaris Partners invests in exceptional technology and healthcare companies across all stages of their life cycles.  With offices in Boston, San Francisco and Dublin, Polaris partners globally with an unparalleled network of repeat entrepreneurs, top scientists and emerging innovators who are making significant contributions in their fields and improving the way in which people live and work.